tiprankstipranks
Advertisement
Advertisement
Liquidia rises 7.7%
PremiumThe FlyLiquidia rises 7.7%
1M ago
Liquidia price target raised to $55 from $50 at H.C. Wainwright
Premium
The Fly
Liquidia price target raised to $55 from $50 at H.C. Wainwright
1M ago
Liquidia: Exceptional Yutrepia Launch, Advancing PH Pipeline, and Strengthening Financial Profile Support Buy Rating
Premium
Ratings
Liquidia: Exceptional Yutrepia Launch, Advancing PH Pipeline, and Strengthening Financial Profile Support Buy Rating
1M ago
Liquidia (LQDA): Durable Competitive Edge and Sustainable Market Share Despite TreSMI Launch Supports Buy Rating
PremiumRatingsLiquidia (LQDA): Durable Competitive Edge and Sustainable Market Share Despite TreSMI Launch Supports Buy Rating
1M ago
Liquidia reaction on United Therapeutics’ TreSMI reveal ‘overdone,’ says Needham
Premium
The Fly
Liquidia reaction on United Therapeutics’ TreSMI reveal ‘overdone,’ says Needham
1M ago
Maintaining Buy on Liquidia: Overreaction to TreSMI News and Attractive Risk-Reward Ahead of ’327 Patent Ruling
Premium
Ratings
Maintaining Buy on Liquidia: Overreaction to TreSMI News and Attractive Risk-Reward Ahead of ’327 Patent Ruling
1M ago
Liquidia falls -6.5%
PremiumThe FlyLiquidia falls -6.5%
3M ago
Liquidia highlights strong YUTREPIA launch and growth plans
Premium
Company Announcements
Liquidia highlights strong YUTREPIA launch and growth plans
3M ago
Liquidia sees Q4 Yutrepia net product sales $90.1M
Premium
The Fly
Liquidia sees Q4 Yutrepia net product sales $90.1M
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100